CVS NYSE
CVS Health Corp.
1W: -3.2%
1M: +3.7%
3M: -14.0%
YTD: +14.6%
1Y: +11.2%
3Y: +43.3%
5Y: +23.8%
$91.13
-1.40 (-1.51%)
Weekly Expected Move ±3.4%
$87
$90
$93
$97
$100
Credit Risk of going bust: lower than 59% of companies Debt: 39.6% of company value Bonds: $1.86B held by 970 funds, 98 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $3.01 (down 97%), CVS Health Corp. would be worth roughly what it owes.
Total debt $76.31B against a stock market value of $116.55B.
Distance to default 6.07 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $31.68B (short-term plus half of long-term), stock volatility 32.1%; Altman Z'' 1.25. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $3.01 (down 97%), CVS Health Corp. would be worth roughly what it owes.
Total debt $76.31B against a stock market value of $116.55B.
Distance to default 6.07 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $31.68B (short-term plus half of long-term), stock volatility 32.1%; Altman Z'' 1.25. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships10
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2022-09-06
Earliest Filing
2024-11-18
Latest Filing
acquirer: 5
target: 3
investor: 2
Counterparties (Filed by CVS)
10 relationshipsCompanies named in CVS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Glenview Capital Management, LLC | — | investor | Entered into a confidentiality agreement regarding potential board appointments and standstill restrictions. | 2024-11-18 | View |
| Oak Street Health | — | target | Target company acquired by CVS Health in a merger for $39.00 per share | 2023-05-02 | View |
| CVS Health Corporation | CVS | acquirer | Parent company of CVS Pharmacy, Inc. entering into a merger agreement. | 2023-02-08 | View |
| CVS Pharmacy, Inc. | CVS | acquirer | Wholly owned direct subsidiary of CVS Health Corporation entering into the Merger Agreement. | 2023-02-08 | View |
| Oak Street Health, Inc. | — | target | Delaware corporation being acquired in the merger, with shares converted to cash. | 2023-02-08 | View |
| Halo Merger Sub Corp. | — | acquirer | Wholly owned direct subsidiary of CVS Pharmacy, Inc. used as the merger vehicle. | 2023-02-08 | View |
| Signify Health, Inc. | — | target | Target company in the merger agreement with CVS Pharmacy, Inc. | 2022-09-06 | View |
| CVS Pharmacy, Inc. | — | acquirer | Parent company entering into the merger agreement to acquire Signify Health, Inc. | 2022-09-06 | View |
| Noah Merger Sub, Inc. | — | acquirer | Wholly-owned subsidiary of CVS Pharmacy, Inc. entering into the merger agreement. | 2022-09-06 | View |
| New Mountain Capital, L.L.C. | — | investor | Affiliate that entered into a voting agreement to support the merger. | 2022-09-06 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-17 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-05-18 | Officer/Director Change; Shareholder Vote | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-03-19 | Officer/Director Change | View | |
| 2026-02-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-20 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-22 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-15 | Other Events; Financial Statements and Exhibits | View | |
| 2025-07-31 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-20 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-08 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-02-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-12-17 | Other Events; Financial Statements and Exhibits | View | |
| 2024-12-10 | Other Events; Financial Statements and Exhibits | View | |
| 2024-12-09 | Other Events; Financial Statements and Exhibits | View | |
| 2024-12-06 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR